| Application no. and date | 15708411.2 (espacenet) (Federated) (European Patent Register), 20150223 | | Patent/reg. no. and date | DK/EP 3110434, 20180919 | | Publication date | 20170104 | | Priority no. and date | US 201461943617 P, 20140224 | | EP pub. no. and date |
EP 3110434 20170104 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045, JP,
Takeda GmbH, Byk-Gulden-Strasse 2
78467 Konstanz, DE | | Applicant ref. no. | P66429DK01 | | Inventor | CHAMBERLAIN, Aaron, Takeda California Inc.
10410 Science Center Drive
San Diego, California 92121, US,
LIU, Qiang, Takeda California Inc.
10410 Science Center Drive
San Diego, California 92121, US,
SCHMIDT, Mathias, Takeda California Inc.
10410 Science Center Drive
San Diego, California 92121, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 14/81 (2006.01) | | Title | UTI FUSIONSPROTEINER | | Int. application no. | US2015017152 | | Int. publication no. | WO2015127391 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
